Work

Efficacy of ISTH0036, a Potent and Selective Antisense Oligonucleotide Targeting Transforming Growth Factor beta 2 (TGF-β2) Isoform, in Different Ocular Disease Preclinical Models

Year: 2015

Type: article

Source: Investigative Ophthalmology & Visual Science

Authors: Michel Janicot, Kathy Hasenbach, Tine Van Bergen, Lieve Moons, Ingeborg Stalmans, Katja Wosikowski

Institutions: Isarna Therapeutics (Germany), KU Leuven

Language: English

Topic: Retinal Diseases and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W588762688

FWCI:

Cites:

Cited by:

Related to: 10